157
Views
0
CrossRef citations to date
0
Altmetric
Review

Updates on bioprosthetic valve fracture

&
Pages 409-422 | Received 14 Mar 2023, Accepted 19 May 2023, Published online: 26 May 2023

References

  • Alkhouli M, Alqahtani F, Kawsara A, et al. National trends in mechanical valve replacement in patients aged 50 to 70 years. J Am Coll Cardiol. 2020;76(22):2687–2688. DOI:10.1016/j.jacc.2020.09.608
  • Zack CJ, Fender EA, Chandrashekar P, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol. 2017;70(24):2953–2960. DOI:10.1016/j.jacc.2017.10.039
  • Alqahtani F, Berzingi CO, Aljohani S, et al. Contemporary trends in the use and outcomes of surgical treatment of tricuspid regurgitation. J Am Heart Assoc. 2017;6(12):e007597. DOI:10.1161/JAHA.117.007597
  • Axtell AL, Bhambhani V, Moonsamy P, et al. Surgery does not improve survival in patients with isolated severe tricuspid regurgitation. J Am Coll Cardiol. 2019;74(6):715–725. DOI:10.1016/j.jacc.2019.04.028
  • Gammie JS, Sheng S, Griffith BP, et al. Trends in mitral valve surgery in the United States: results from the society of thoracic surgeons adult cardiac surgery database. Ann Thorac Surg. 2009;87(5):1431–1437. DOI:10.1016/j.athoracsur.2009.01.064
  • Kaneko T, Vassileva CM, Englum B, et al. Contemporary outcomes of repeat aortic valve replacement: a benchmark for transcatheter valve-in-valve procedures. Ann Thorac Surg. 2015;100(4):100(4)1298–304. DOI:10.1016/j.athoracsur.2015.04.062
  • Lee C, Park CS, Lee CH, et al. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg. 2011;142(2):351–358. DOI:10.1016/j.jtcvs.2010.12.020
  • Nomoto R, Sleeper LA, Borisuk MJ, et al. Outcome and performance of bioprosthetic pulmonary valve replacement in patients with congenital heart disease. J Thorac Cardiovasc Surg. 2016;152(5):1333–42.e3. DOI:10.1016/j.jtcvs.2016.06.064
  • Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;77(4):e25–197. DOI:10.1016/j.jacc.2020.11.018
  • Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561–632. DOI:10.1093/eurheartj/ehab395
  • Jeganathan R, Armstrong S, Al-Alao B, et al. The risk and outcomes of reoperative tricuspid valve surgery. Ann Thorac Surg. 2013;95(1):119–124.
  • Lee C, Lee CH, Kwak JG. Outcomes of redo pulmonary valve replacement for bioprosthetic pulmonary valve failure in 61 patients with congenital heart disease. Eur J Cardiothorac Surg. 2016;50(3):470–475.
  • Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014;312(2):162–170. DOI:10.1001/jama.2014.7246
  • Ye J, Cheung A, Yamashita M, et al. Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves: an 8-year single-center experience. JACC: Cardiovasc Interv. 2015;8(13):1735–1744. DOI:10.1016/j.jcin.2015.08.012
  • Pibarot P, Dumesnil JG. Prosthesis-patient mismatch: definition, clinical impact, and prevention. Heart. 2006;92(8):1022–1029.
  • Pibarot P, Dumesnil JG. Valve prosthesis-patient mismatch, 1978 to 2011: from original concept to compelling evidence. J Am Coll Cardiol. 2012;60(13):1136–1139.
  • Kalra A, Raza S, Hussain M, et al. Aortic valve replacement in bioprosthetic failure: insights from the society of thoracic surgeons national database. Ann Thorac Surg. 2020;110(5):1637–1642. DOI:10.1016/j.athoracsur.2019.08.023
  • Sá MPBO, Van den Eynde J, Simonato M, et al. Valve-in-valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement: an updated meta-analysis. JACC: Cardiovasc Interv. 2021;14(2):211–220. DOI:10.1016/j.jcin.2020.10.020
  • Sá MP, Van den Eynde J, Simonato M, et al. Late outcomes of valve-in-valve transcatheter aortic valve implantation versus re-replacement: meta-analysis of reconstructed time-to-event data. Int J Cardiol. 2023;370:112–121.
  • Tuzcu EM, Kapadia SR, Vemulapalli S, et al. Transcatheter aortic valve replacement of failed surgically implanted bioprostheses: the STS/ACC registry. J Am Coll Cardiol. 2018;72(4):370–382. DOI:10.1016/j.jacc.2018.04.074
  • Dallan LAP, Forrest JK, Reardon MJ, et al. Transcatheter aortic valve replacement with self-expandable supra-annular valves for degenerated surgical bioprostheses: insights from transcatheter valve therapy registry. J Am Heart Assoc. 2021;10(18):e021871. DOI:10.1161/JAHA.121.021871
  • Kaneko T, Makkar RR, Krishnaswami A, et al. Valve-in-Surgical-Valve with SAPIEN 3 for transcatheter aortic valve replacement based on society of thoracic surgeons predicted risk of mortality. Circ Cardiovasc Interv. 2021;14(5):e010288. DOI:10.1161/CIRCINTERVENTIONS.120.010288
  • Faerber G, Schleger S, Diab M, et al. Valve-invalve transcatheter aortic valve implantation: the new playground for prosthesis-patient mismatch. J Interv Cardiol. 2014;27(3):287–292. DOI:10.1111/joic.12108
  • Bleiziffer S, Simonato M, Webb JG, et al. Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves. Eur Heart J. 2020;41(29):2731–2742. DOI:10.1093/eurheartj/ehaa544
  • Dvir D, Webb J, Brecker S, et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation. 2012;126(19):2335–2344. DOI:10.1161/CIRCULATIONAHA.112.104505
  • Pibarot P, Simonato M, Barbanti M, et al. Impact oF pre-existing prosthesis-patient mismatch on survival following aortic valve-in-valve procedures. JACC: Cardiovasc Interv. 2018;11(2):133–141. DOI:10.1016/j.jcin.2017.08.039
  • Dauerman HL, Deeb GM, O’Hair DP, et al. Durability and clinical outcomes of transcatheter aortic valve replacement for failed surgical bioprostheses. Circ Cardiovasc Interv. 2019;12(10):e008155. DOI:10.1161/CIRCINTERVENTIONS.119.008155
  • Sá MP, Jacquemyn X, Van den Eynde J, et al. Impact of prosthesis-patient mismatch after transcatheter aortic valve replacement: meta-analysis of Kaplan-Meier-derived individual patient data. JACC Cardiovasc Imaging. 2023;16(3):298–310. DOI:10.1016/j.jcmg.2022.07.013
  • Azadani AN, Jaussaud N, Matthews PB, et al. Valve-in-valve implantation using a novel supravalvular transcatheter aortic valve: proof of concept. Ann Thorac Surg. 2009;88(6):1864–1869. DOI:10.1016/j.athoracsur.2009.08.004
  • Dvir D. Treatment of small surgical valves: clinical considerations for achieving optimal results in valve-in-valve procedures. JACC: Cardiovasc Interv. 2015;8(15):2034–2036.
  • Simonato M, Webb J, Kornowski R, et al. Transcatheter replacement of failed bioprosthetic valves: large multicenter assessment of the effect of implantation depth on hemodynamics after aortic valve-in-valve. Circ Cardiovasc Interv. 2016;9(6):e003651. DOI:10.1161/CIRCINTERVENTIONS.115.003651
  • Tanase D, Grohmann J, Schubert S, et al. Cracking the ring of Edwards Perimount bioprosthesis with ultrahigh pressure balloons prior to transcatheter valve in valve implantation. Int J Cardiol. 2014;176(3):1048–1049. DOI:10.1016/j.ijcard.2014.07.175
  • Nielsen-Kudsk JE, Christiansen EH, Terkelsen CJ, et al. Fracturing the ring of small mitroflow bioprostheses by high-pressure balloon predilatation in transcatheter aortic valve-in-valve implantation. Circ Cardiovasc Interv. 2015;8(8):e002667. DOI:10.1161/CIRCINTERVENTIONS.115.002667
  • Thourani VH, Suri RM, Gunter RL, et al. Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients. Ann Thorac Surg. 2015;99(1):55–61. DOI:10.1016/j.athoracsur.2014.06.050
  • Abbasi M, Azadani AN. Leaflet stress and strain distributions following incomplete transcatheter aortic valve expansion. J Biomech. 2015;48(13):3663–3671.
  • Midha PA, Raghav V, Condado JF, et al. Valve type, size, and deployment location affect hemodynamics in an in vitro valve-in-valve model. JACC: Cardiovasc Interv. 2016;9(15):1618–1628. DOI:10.1016/j.jcin.2016.05.030
  • Martin C, Sun W. Transcatheter valve underexpansion limits leaflet durability: implications for valve-in-valve procedures. Ann Biomed Eng. 2017;45(2):394–404.
  • Gunning PS, Saikrishnan N, Yoganathan AP, et al. Total ellipse of the heart valve: the impact of eccentric stent distortion on the regional dynamic deformation of pericardial tissue leaflets of a transcatheter aortic valve replacement. J R Soc Interface. 2015;12(113):20150737.
  • Grubitzsch H, Galloni M, Falk V. Wrinkles, folds and calcifications: reduced durability after transcatheter aortic valve-in-valve replacement. J Thorac Cardiovasc Surg. 2017;153(2):266–268.
  • Sathananthan J, Sellers S, Barlow AM, et al. Valve-in-valve transcatheter aortic valve replacement and bioprosthetic valve fracture comparing different transcatheter heart valve designs: an ex vivo bench study. JACC: Cardiovasc Interv. 2019;12(1):65–75. DOI:10.1016/j.jcin.2018.10.043
  • Sathananthan J, Fraser R, Hatoum H, et al. A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention. EuroIntervention. 2020;15(16):1409–1416. DOI:10.4244/EIJ-D-19-00939
  • Johansen P, Engholt H, Tang M, et al. Fracturing mechanics before valve-in-valve therapy of small aortic bioprosthetic heart valves. EuroIntervention. 2017;13(9):e1026–31. DOI:10.4244/EIJ-D-17-00245
  • Allen KB, Chhatriwalla AK, Cohen DJ, et al. Bioprosthetic valve fracture to facilitate transcatheter valve-in-valve implantation. Ann Thorac Surg. 2017;104(5):1501–1508. DOI:10.1016/j.athoracsur.2017.04.007
  • Meier D, Payne GW, Mostaço-Guidolin LB, et al. Timing of bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity. EuroIntervention. 2023;18(14):1165–1177. DOI:10.4244/EIJ-D-22-00644
  • Saxon JT, Allen KB, Cohen DJ, et al. Bioprosthetic valve remodeling of trifecta surgical valves to facilitate valve-in-valve TAVR. Struct Heart. 2020;4(2):99–104. DOI:10.1080/24748706.2019.1704102
  • Bapat VN, Attia R, Thomas M. Effect of valve design on the stent internal diameter of a bioprosthetic valve: a concept of true internal diameter and its implications for the valve-invalve procedure. JACC: Cardiovasc Interv. 2014;7(2):115–127.
  • Shahanavaz S, Asnes JD, Grohmann J, et al. IntentionaL fracture of bioprosthetic valve frames in patients undergoing valve-in-valve transcatheter pulmonary valve replacement. Circ Cardiovasc Interv. 2018;11(8):e006453. DOI:10.1161/CIRCINTERVENTIONS.118.006453
  • Ruge H, Alvarez-Covarrubias HA, Deutsch O, et al. Bioprosthetic valve fracturing: in vitro testing of Edwards PERIMOUNT model P 2900. Front Cardiovasc Med. 2022 Jun 2;9:859088. DOI:10.3389/fcvm.2022.859088
  • Sedaghat A, Sinning JM, Utzenrath M, et al. Hydrodynamic performance of the Medtronic CoreValve and the Edwards SAPIEN XT transcatheter heart valve in surgical bioprostheses: an in vitro valve-in-valve model. Ann Thorac Surg. 2016;101(1):118–124. DOI:10.1016/j.athoracsur.2015.06.047
  • Ochiai T, Yoon SH, Sharma R, et al. Outcomes of self-expanding vs. balloon-expandable transcatheter heart valves for the treatment of degenerated aortic surgical bioprostheses - a propensity score-matched comparison. Circ J. 2018;82(10):2655–2662. DOI:10.1253/circj.CJ-18-0157
  • Rodés-Cabau J, Abbas AE, Serra V, et al. Balloon- vs self-expanding valve systems for failed small surgical aortic valve bioprostheses. J Am Coll Cardiol. 2022;80(7):681–693. DOI:10.1016/j.jacc.2022.05.005
  • Hayashida K. Transcatheter valve treatment for a failed small surgical aortic valve: addressing the achilles’ heel. J Am Coll Cardiol. 2022;80(7):694–696.
  • Chhatriwalla AK, Allen KB, Saxon JT, et al. 1-Year outcomes following bioprosthetic valve fracture to facilitate valve-in-valve transcatheter aortic valve replacement. Structural Heart. 2021;5(3):312–318. DOI:10.1080/24748706.2021.1895456
  • Brinkmann C, Abdel-Wahab M, Bedogni F, et al. Bioprosthetic valve fracture: predictors of outcome and follow-up. Results from a multicenter study. Catheter Cardiovasc Interv. 2021;98(4):756–764. DOI:10.1002/ccd.29755
  • Allen KB, Chhatriwalla AK, Saxon JT, et al. Bioprosthetic valve fracture investigators. bioprosthetic valve fracture: technical insights from a multicenter study. J Thorac Cardiovasc Surg. 2019;158(5):1317–28.e1. DOI:10.1016/j.jtcvs.2019.01.073
  • Chhatriwalla AK, Allen KB, Depta JP, et al. Outcomes of bioprosthetic valve fracture in patients undergoing valve-in-valve TAVR. J Am Coll Cardiol Intv. 2023;16(5):530–539. DOI:10.1016/j.jcin.2022.12.019
  • Maleki H, Shahriari S, Labrosse M, et al. Effect of aortic annulus size and prosthesis oversizing on the hemodynamics and leaflet bending stress of transcatheter valves: an in vitro study. Can J Cardiol. 2015;31(8):1041–1046. DOI:10.1016/j.cjca.2015.03.026
  • Sathananthan J, Hensey M, Sellers S, et al. Performance of the TRUE dilatation balloon valvuloplasty catheter beyond rated burst pressure: a bench study. Catheter Cardiovasc Interv. 2020;96(2):E187–95. DOI:10.1002/ccd.28503
  • Chhatriwalla AK, Allen KB, Saxon JT, et al. Bioprosthetic valve fracture improves the hemodynamic results of valve-in-valve transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2017;10(7):e005216. DOI:10.1161/CIRCINTERVENTIONS.117.005216
  • Allen KB, Chhatriwalla AK, Yousef A, et al. https://meetings.ismics.org/abstracts/2020/C9.cgi. Accessed Jan 3, 2023.
  • Nielsen-Kudsk JE, Andersen A, Therkelsen CJ, et al. High-pressure balloon fracturing of small dysfunctional Mitroflow bioprostheses facilitates transcatheter aortic valve-in-valve implantation. EuroIntervention. 2017;13(9):e1020–5. DOI:10.4244/EIJ-D-17-00244
  • Brinkmann C, Abdel-Wahab M, Bedogni F, et al. Outcomes of valve-in-valve transcatheter aortic valve implantation with and without bioprosthetic valve fracture. EuroIntervention. 2021;17(10):848–855. DOI:10.4244/EIJ-D-21-00254
  • Sá MP, Rayol SC, Van den Eynde J, et al. Bioprosthetic valve fracture for valve-in-valve transcatheter aortic valve implantation in patients with structural valve degeneration: systematic review with meta-analysis. J Card Surg. 2021;36(12):4722–4731. DOI:10.1111/jocs.16032
  • Saxon JT, Allen KB, Cohen DJ, et al. Complications of bioprosthetic valve fracture as an adjunct to valve-in-valve TAVR. Struct Heart. 2019;3(2):92–99. DOI:10.1080/24748706.2019.1578446
  • Ballout E, Combaret N, Riocreux C, et al. Leaflet disruption of ViV-TAVI after bioprosthetic valve fracture leading to severe aortic regurgitation: a case report. Eur Heart J Case Rep. 2022;6(8):ytac313.
  • Dvir D, Leipsic J, Blanke P, et al. Coronary obstruction in transcatheter aortic valve-in-valve implantation: preprocedural evaluation, device selection, protection, and treatment. Circ Cardiovasc Interv. 2015;8(1):e002079. DOI:10.1161/CIRCINTERVENTIONS.114.002079
  • Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J. 2018;39(8):687–695. DOI:10.1093/eurheartj/ehx455
  • Lederman RJ, Babaliaros VC, Rogers T, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: from computed tomography to BASILICA. JACC: Cardiovasc Interv. 2019;12(13):1197–1216. DOI:10.1016/j.jcin.2019.04.052
  • INSPIRIS RESILIA Aortic Valve, Model 11500A [Package insert]. Irvine: CA: Edwards Life Sciences; 2018. Available at: https://www.accessdata.fda.gov/cdrhdocs/pdf15/P150048D.pdf. Accessed Jan 13, 2023.
  • O’Byrne ML, Glatz AC, Mercer-Rosa L, et al. Trends in pulmonary valve replacement in children and adults with tetralogy of fallot. Am J Cardiol. 2015;115(1):118–124. DOI:10.1016/j.amjcard.2014.09.054
  • Khanna AD, Hill KD, Pasquali SK, et al. Benchmark outcomes for pulmonary valve replacement using the society of thoracic surgeons databases. Ann Thorac Surg. 2015;100(1):138–145. DOI:10.1016/j.athoracsur.2015.03.025
  • Solomon NA, Pranav SK, Jain KA, et al. In search of a pediatric cardiac surgeon’s ‘Holy Grail’: the ideal pulmonary conduit. Expert Rev Cardiovasc Ther. 2006;4(6):861–870. DOI:10.1586/14779072.4.6.861
  • Zahn EM, Hellenbrand WE, Lock JE, et al. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the u.S. Clinical trial. J Am Coll Cardiol. 2009;54(18):1722–1729.
  • Cheatham JP, Hellenbrand WE, Zahn EM, et al. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial. Circulation. 2015;131(22):1960–1970. DOI:10.1161/CIRCULATIONAHA.114.013588
  • Gillespie MJ, Rome JJ, Levi DS, et al. Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv. 2012;5(6):862–870. DOI:10.1161/CIRCINTERVENTIONS.112.972216
  • Cabalka AK, Asnes JD, Balzer DT, et al. Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: a multicenter study. J Thorac Cardiovasc Surg. 2018;155(4):1712–1724. DOI:10.1016/j.jtcvs.2017.10.143
  • Jones TK, McElhinney DB, Vincent JA, et al. Long-term outcomes after melody transcatheter pulmonary valve replacement in the US investigational device exemption trial. Circ Cardiovasc Interv. 2022;15(1):e010852. DOI:10.1161/CIRCINTERVENTIONS.121.010852
  • Kenny D, Rhodes JF, Fleming GA, et al. 3- year outcomes of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position from the compassion multicenter clinical Trial. JACC: Cardiovasc Interv. 2018;11(19):1920–1929. DOI:10.1016/j.jcin.2018.06.001
  • Morgan GJ, Sadeghi S, Salem MM, et al. SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without “pre-stenting”: a multi-institutional experience. Catheter Cardiovasc Interv. 2019;93(2):324–329. DOI:10.1002/ccd.27932
  • Shahanavaz S, Berger F, Jones TK, et al. Outcomes after transcatheter reintervention for dysfunction of a previously implanted transcatheter pulmonary valve. JACC: Cardiovasc Interv. 2020;13(13):1529–1540. DOI:10.1016/j.jcin.2020.03.035
  • Morray BH, McElhinney DB, Cheatham JP, et al. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience. Circ Cardiovasc Interv. 2013;6(5):535–542. DOI:10.1161/CIRCINTERVENTIONS.113.000202
  • Fraisse A, Assaidi A, Mauri L, et al. Coronary artery compression during intention to treat right ventricle outflow with percutaneous pulmonary valve implantation: incidence, diagnosis, and outcome. Catheter Cardiovasc Interv. 2014;83(7):E260–8. DOI:10.1002/ccd.25471
  • Kjaergaard J, Iversen KK, Vejlstrup NG, et al. Impacts of acute severe pulmonary regurgitation on right ventricular geometry and contractility assessed by tissue-Doppler echocardiography. Eur J Echocardiogr. 2010;11(1):19–26. DOI:10.1093/ejechocard/jep149
  • McElhinney DB, Cheatham JP, Jones TK, et al. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial. Circ Cardiovasc Interv. 2011;4(6):602–614. DOI:10.1161/CIRCINTERVENTIONS.111.965616
  • Cabalka AK, Hellenbrand WE, Eicken A, et al. Relationships among conduit type, pre-stenting, and outcomes in patients undergoing transcatheter pulmonary valve replacement in the prospective North American and European Melody Valve Trials. JACC: Cardiovasc Interv. 2017;10(17):1746–1759. DOI:10.1016/j.jcin.2017.05.022
  • Bourguignon T, Bouquiaux-Stablo AL, Loardi C, et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations. J Thorac Cardiovasc Surg. 2014;148(5):2004–2011. DOI:10.1016/j.jtcvs.2014.02.050
  • Ejiofor JI, Hirji SA, Ramirez-Del Val F, et al. Outcomes of repeat mitral valve replacement in patients with prior mitral surgery: a benchmark for transcatheter approaches. J Thorac Cardiovasc Surg. 2018;156(2):619–627. DOI:10.1016/j.jtcvs.2018.03.126
  • Mehaffey HJ, Hawkins RB, Schubert S, et al. Contemporary outcomes in reoperative mitral valve surgery. Heart. 2018;104(8):652–656. DOI:10.1136/heartjnl-2017-312047
  • Sengupta A, Yazdchi F, Alexis SL, et al. Reoperative mitral surgery versus transcatheter mitral valve replacement: a systematic review. J Am Heart Assoc. 2021;10(6):e019854. DOI:10.1161/JAHA.120.019854
  • Whisenant B, Kapadia SR, Eleid MF, et al. One-year outcomes of mitral valve-in-valve using the SAPIEN 3 transcatheter heart valve. JAMA Cardiol. 2020;5(11):1245–1252. DOI:10.1001/jamacardio.2020.2974
  • Simonato M, Whisenant B, Ribeiro HB, et al. Transcatheter mitral valve replacement after surgical repair or replacement: comprehensive midterm evaluation of valve-in-valve and valve-in-ring implantation from the VIVID Registry. Circulation. 2021;143(2):104–116. DOI:10.1161/CIRCULATIONAHA.120.049088
  • Zia Khan M, Zahid S, Khan MU, et al. Redo Surgical Mitral Valve Replacement Versus Transcatheter Mitral Valve In Valve From The National Inpatient Sample. J Am Heart Assoc. 2021;10(17):e020948. DOI:10.1161/JAHA.121.020948
  • Yoon SH, Whisenant BK, Bleiziffer S, et al. Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty rings. J Am Coll Cardiol. 2017;70(9):1121–1131. DOI:10.1016/j.jacc.2017.07.714
  • Evin M, Guivier-Curien C, Rieu R, et al. Mitral valve-in-valve hemodynamic performance: an in vitro study. J Thorac Cardiovasc Surg. 2016;151(4):1051–9.e6. DOI:10.1016/j.jtcvs.2015.11.039
  • Kaneko T, Piccirillo B, Golwala H, et al. Balloon fracture of a surgical mitral bioprosthesis during valve-in-valve transcatheter mitral valve replacement: first-in-human report. Circ Cardiovasc Interv. 2018;11(1):e006273. DOI:10.1161/CIRCINTERVENTIONS.117.006273
  • Kamioka N, Corrigan F, Iturbe JM, et al. Mitral bioprosthetic valve fracture: bailout procedure for undersized bioprosthesis during mitral valve-in-valve procedure with paravalvular leak closure. JACC: Cardiovasc Interv. 2018;11(3):e21–2. DOI:10.1016/j.jcin.2017.10.047
  • Asgar A, Ducharme A, Messas N, et al. Left ventricular outflow tract obstruction following mitral valve replacement: challenges for transcatheter mitral valve therapy. Structural Heart. 2018;2(5):372–379. DOI:10.1080/24748706.2018.1494397
  • Urena M, Himbert D, Brochet E, et al. Transseptal transcatheter mitral valve replacement using balloon-expandable transcatheter heart valves: a step-by-step approach. JACC: Cardiovasc Interv. 2017;10(19):1905–1919. DOI:10.1016/j.jcin.2017.06.069
  • Reid A, Ben Zekry S, Turaga M, et al. Neo-LVOT and transcatheter mitral valve replacement: expert recommendations. JACC Cardiovasc Imaging. 2021;14(4):854–866. DOI:10.1016/j.jcmg.2020.09.027
  • Engel Gonzalez P, Turer AT, Doolabh N, et al. Preemptive alcohol septal ablation prior to valve-in-valve transcatheter mitral valve replacement with bioprosthetic balloon fracture. JACC Case Rep. 2021;3(3):366–369. DOI:10.1016/j.jaccas.2020.12.021
  • Guenther T, Noebauer C, Mazzitelli D, et al. Tricuspid valve surgery: a thirty-year assessment of early and late outcome. Eur J Cardiothorac Surg. 2008;34(2):402–409.
  • Marquis-Gravel G, Bouchard D, Perrault LP, et al. Retrospective cohort analysis of 926 tricuspid valve surgeries: clinical and hemodynamic outcomes with propensity score analysis. Am Heart J. 2012;163(5):851–8.e1. DOI:10.1016/j.ahj.2012.02.010
  • McElhinney DB, Cabalka AK, Aboulhosn JA, et al. Valve-in-Valve International Database (VIVID) registry. transcatheter tricuspid valve-in-valve implantation for the treatment of dysfunctional surgical bioprosthetic valves: an international, multicenter registry study. Circulation. 2016;133(16):1582–1593. DOI:10.1161/CIRCULATIONAHA.115.019353
  • Brown SC, Cools B, Gewillig M. Cracking a tricuspid perimount bioprosthesis to optimize a second transcatheter sapien valve-in-valve placement. Catheter Cardiovasc Interv. 2016;88(3):456–459.
  • Karahalios B, Breinholt JP, Little SH, et al. Intentional bioprosthetic tricuspid valve fracture to facilitate transcatheter valve-in-valve deployment. Catheter Cardiovasc Interv. 2021;97(2):361–364.
  • Hensey M, Alenezi AR, Murdoch DJ, et al. Transcatheter tricuspid valve-in-valve replacement with subsequent bioprosthetic valve fracture to optimize hemodynamic function. JACC: Cardiovasc Interv. 2018;11(21):2226–2227. DOI:10.1016/j.jcin.2018.06.011
  • McElhinney DB, Aboulhosn JA, Dvir D, et al. VIVID registry. mid-term valve-related outcomes after transcatheter tricuspid valve-in-valve or valve-in-ring replacement. J Am Coll Cardiol. 2019;73(2):148–157. DOI:10.1016/j.jacc.2018.10.051
  • Blauwet LA, Danielson GK, Burkhart HM, et al. Comprehensive echocardiographic assessment of the hemodynamic parameters of 285 tricuspid valve bioprostheses early after implantation. J Am Soc Echocardiogr. 2010;23(10):1045–1059. DOI:10.1016/j.echo.2010.08.007

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.